Manchester Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07K | Hold |
|
|||||
|
2025
Q1 | $3.84K | Hold |
|
|||||
|
2024
Q4 | $6.3K | Hold |
|
|||||
|
2024
Q3 | $11.1K | Hold |
|
|||||
|
2024
Q2 | $12.1K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $63.2K | Hold |
|
|||||
|
2023
Q2 | $81.6K | Hold |
|
|||||
|
2023
Q1 | $74.5K | Hold |
|
|||||
|
2022
Q4 | $69.8K | Hold |
|
|||||
|
2022
Q3 | $112K | Hold |
|
|||||
|
2022
Q2 | $104K | Hold |
|
|||||
|
2022
Q1 | $145K | Sell |
|
|||||
|
2021
Q4 | $249K | Hold |
|
|||||
|
2021
Q3 | $282K | Buy |
|